NZ791994A - Compositions for disrupting biofilm formation and for treating biofilm-related disorders - Google Patents
Compositions for disrupting biofilm formation and for treating biofilm-related disordersInfo
- Publication number
- NZ791994A NZ791994A NZ791994A NZ79199421A NZ791994A NZ 791994 A NZ791994 A NZ 791994A NZ 791994 A NZ791994 A NZ 791994A NZ 79199421 A NZ79199421 A NZ 79199421A NZ 791994 A NZ791994 A NZ 791994A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compositions
- biofilm
- related disorders
- treating
- disrupting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/04—Sulfonic acids; Derivatives thereof
- A01N41/08—Sulfonic acid halides; alpha-Hydroxy-sulfonic acids; Amino-sulfonic acids; Thiosulfonic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/04—Thiosulfonates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Animal Husbandry (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Agronomy & Crop Science (AREA)
- Birds (AREA)
- Mycology (AREA)
- Dentistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20163157 | 2020-03-13 | ||
| PCT/NL2021/050168 WO2021182958A1 (en) | 2020-03-13 | 2021-03-12 | Compositions for disrupting biofilm formation and for treating biofilm-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ791994A true NZ791994A (en) | 2026-03-27 |
Family
ID=69844589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ791994A NZ791994A (en) | 2020-03-13 | 2021-03-12 | Compositions for disrupting biofilm formation and for treating biofilm-related disorders |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20230000811A1 (https=) |
| EP (1) | EP4117654B1 (https=) |
| JP (1) | JP7835682B2 (https=) |
| KR (1) | KR20220154142A (https=) |
| CN (1) | CN115397409A (https=) |
| AU (1) | AU2021234626A1 (https=) |
| BR (1) | BR112022017193A2 (https=) |
| CA (1) | CA3168188A1 (https=) |
| CL (2) | CL2022002463A1 (https=) |
| CO (1) | CO2022013742A2 (https=) |
| EC (1) | ECSP22079392A (https=) |
| ES (1) | ES3055402T3 (https=) |
| HR (1) | HRP20251520T1 (https=) |
| IL (1) | IL296302A (https=) |
| MX (1) | MX2022011359A (https=) |
| NZ (1) | NZ791994A (https=) |
| PE (1) | PE20230174A1 (https=) |
| PL (1) | PL4117654T3 (https=) |
| WO (1) | WO2021182958A1 (https=) |
| ZA (1) | ZA202209257B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12428372B2 (en) | 2022-04-14 | 2025-09-30 | Saudi Arabian Oil Company | ODSO acid medium, ODSO acid mixture medium, and uses thereof |
| CN119278033A (zh) | 2022-04-14 | 2025-01-07 | Ahv国际有限公司 | 减少泌乳和改善健康的化合物 |
| CN118240713B (zh) * | 2024-05-27 | 2024-09-20 | 吉林大学 | 一种枯草芽孢杆菌及其在防治奶牛乳腺炎方面的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2413563A (en) * | 2004-04-27 | 2005-11-02 | Micap Plc | Composition comprising a biocide encapsulated within a fungal cell |
| KR100750750B1 (ko) * | 2005-09-27 | 2007-08-30 | 대한민국 | 식물성 정유 및 정유 성분을 유효성분으로 포함하는 살선충성 조성물 |
| ES2311373B1 (es) | 2006-09-27 | 2009-12-21 | Dmc Research Center, S.L. | "utilizacion de un compuesto antibacteriano derivado de alliaceas, como aditivos en alimentacion animal". |
| FR2958118B1 (fr) * | 2010-04-01 | 2012-06-15 | Pancosma Sa Pour L Ind Des Produits Biochimiques | Utilisation d'au moins un thiosulfinate ou thiosulfonate de dialkyle pour reduire le nombre d'apicomplexes chez un animal monogastrique |
| ES2571998T3 (es) * | 2010-12-08 | 2016-05-27 | Univ Danmarks Tekniske | Composiciones y usos médicos de derivados del ajoeno |
| US10086018B2 (en) * | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| EP3338774A1 (fr) * | 2016-12-23 | 2018-06-27 | Mixscience | Composition à base de composés thiosulfinate et/ou de thiosulfonate pour son utilisation dans la prévention des infections bactériennes chez les animaux aquatiques |
| CN110753698A (zh) * | 2017-01-31 | 2020-02-04 | 奇达拉治疗公司 | 用于治疗真菌感染的方法 |
-
2021
- 2021-03-12 KR KR1020227034718A patent/KR20220154142A/ko active Pending
- 2021-03-12 BR BR112022017193A patent/BR112022017193A2/pt unknown
- 2021-03-12 JP JP2022554867A patent/JP7835682B2/ja active Active
- 2021-03-12 PE PE2022001941A patent/PE20230174A1/es unknown
- 2021-03-12 PL PL21712254.8T patent/PL4117654T3/pl unknown
- 2021-03-12 HR HRP20251520TT patent/HRP20251520T1/hr unknown
- 2021-03-12 WO PCT/NL2021/050168 patent/WO2021182958A1/en not_active Ceased
- 2021-03-12 CN CN202180020565.4A patent/CN115397409A/zh active Pending
- 2021-03-12 AU AU2021234626A patent/AU2021234626A1/en active Pending
- 2021-03-12 CA CA3168188A patent/CA3168188A1/en active Pending
- 2021-03-12 EP EP21712254.8A patent/EP4117654B1/en active Active
- 2021-03-12 US US17/905,772 patent/US20230000811A1/en active Pending
- 2021-03-12 NZ NZ791994A patent/NZ791994A/en unknown
- 2021-03-12 IL IL296302A patent/IL296302A/en unknown
- 2021-03-12 MX MX2022011359A patent/MX2022011359A/es unknown
- 2021-03-12 ES ES21712254T patent/ES3055402T3/es active Active
-
2022
- 2022-08-17 ZA ZA2022/09257A patent/ZA202209257B/en unknown
- 2022-09-09 CL CL2022002463A patent/CL2022002463A1/es unknown
- 2022-09-26 CO CONC2022/0013742A patent/CO2022013742A2/es unknown
- 2022-10-12 EC ECSENADI202279392A patent/ECSP22079392A/es unknown
-
2025
- 2025-04-24 CL CL2025001219A patent/CL2025001219A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021234626A1 (en) | 2022-09-29 |
| IL296302A (en) | 2022-11-01 |
| JP2023518928A (ja) | 2023-05-09 |
| CA3168188A1 (en) | 2021-09-16 |
| US20230000811A1 (en) | 2023-01-05 |
| BR112022017193A2 (pt) | 2022-10-18 |
| ECSP22079392A (es) | 2022-11-30 |
| ES3055402T3 (en) | 2026-02-11 |
| JP7835682B2 (ja) | 2026-03-25 |
| EP4117654A1 (en) | 2023-01-18 |
| CO2022013742A2 (es) | 2022-10-31 |
| EP4117654B1 (en) | 2025-11-05 |
| CL2022002463A1 (es) | 2023-06-16 |
| KR20220154142A (ko) | 2022-11-21 |
| CL2025001219A1 (es) | 2026-02-20 |
| MX2022011359A (es) | 2022-12-02 |
| HRP20251520T1 (hr) | 2026-02-13 |
| EP4117654C0 (en) | 2025-11-05 |
| PL4117654T3 (pl) | 2026-02-23 |
| WO2021182958A1 (en) | 2021-09-16 |
| PE20230174A1 (es) | 2023-02-01 |
| CN115397409A (zh) | 2022-11-25 |
| ZA202209257B (en) | 2025-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202209257B (en) | Compositions for disrupting biofilm formation and for treating biofilm-related disorders | |
| MX346409B (es) | Tioles de bismuto como antisepticos para usos biomedicos, que incluyen tratamiento de biopeliculas bacterianas y otros usos. | |
| MX2019010863A (es) | Tioles de bismuto como antisepticos para usos biomedicos, que incluyen tratamiento de biopeliculas bacterianas y otros usos. | |
| WO2020160193A3 (en) | Compounds and uses thereof | |
| MX2023012245A (es) | Compuestos, composiciones y metodos para el tratamiento del cancer. | |
| UA109876C2 (uk) | Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів | |
| WO2021158635A8 (en) | Anti-viral compositions and methods of use | |
| WO2022020353A3 (en) | Methods and compositions for treatment and prevention of coronavirus infection | |
| SA522431538B1 (ar) | طُرق وتركيبات لعلاج تساقط الشعر | |
| WO2021262735A3 (en) | Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokine-release syndrome and cytokine storm associated disorders | |
| JOP20210264A1 (ar) | مركبات نورجولين-4 وطرق استخدامها | |
| WO2024163641A3 (en) | Formulations for treating cancer | |
| WO2024006292A3 (en) | Methods of treating cancer | |
| PH12021553164A1 (en) | Biofilm disruption | |
| MX2023010941A (es) | Compuestos antibacterianos. | |
| MX2023002113A (es) | Composicion que contiene dioxido de cloro y metodos para su uso. | |
| MX2022006109A (es) | Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa. | |
| WO2023285654A3 (en) | Compounds for the treatment of covid-19 | |
| MX2022003816A (es) | Compuestos antibacterianos. | |
| MX2022003814A (es) | Compuestos antibacterianos de 4-quinolinona. | |
| WO2022040238A3 (en) | Engineered arenavirus glycoprotein compositions and methods of use thereof | |
| WO2023034914A3 (en) | Methods for the prevention and treatment of synucleinopathies | |
| MX2023010947A (es) | Compuestos antibacterianos. | |
| EP4135721A4 (en) | Treatment of adverse effects caused by atypical antipsychotics | |
| HK40095673A (en) | Allogeneic composition for treatment of covid-19 |